SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: richard davis who wrote (631)10/13/1996 8:10:00 PM
From: Nikole Wollerstein   of 4342
 
I afraid next time I will open SI there will be site: Nikita myth or reality?
Here are all answers:
I work in UCSF/Dept Biochemistry on cell cycle control. We do not have any collaboration with PRLN yet. I have big position in PRLN: 20% off portfolio, I double it
in the resent decline and sleep well.
I do not know anything about PRLN beyond publicly available info.
I expect PRLN will be above $20.
My suggestion that PRLN will be halted on the news release was half speculation half a joke. I was just annoyed by pointless chat on the site at this moment(most other times it is very informative), but I was partially right - there was very important news(financing) but no halt. Soon we should get news from next group of 30 patients that receive p27 Does anybody know what happened with the first group of 7?
I rarely invest in biotech because of the poor risk /reward ratio. By the time the drug is on the market they sold so many shares that upside is limited. (Gold mining used to have better risk/reward, not any more.) PRLN is an exception since their approach is so cheap.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext